Page last updated: 2024-11-04

risedronic acid and Deficiency, Vitamin K

risedronic acid has been researched along with Deficiency, Vitamin K in 2 studies

Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.

Research Excerpts

ExcerptRelevanceReference
"Risedronate does not suppress bone resorption deeply that enhances the bone recovers quickly after withdrawal."2.71Monitoring of Risedronate by biochemical bone markers in clinical practice. ( Bunyaratavej, N, 2005)
"Treatment with menatetrenone, risedronate or regular sunlight exposure are safe and effective in increasing bone mass and reducing the risk of hip fracture in patients with AD."2.46[Dementia and fracture]. ( Sato, Y, 2010)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, Y1
Bunyaratavej, N1

Reviews

1 review available for risedronic acid and Deficiency, Vitamin K

ArticleYear
[Dementia and fracture].
    Clinical calcium, 2010, Volume: 20, Issue:9

    Topics: Accidental Falls; Bone Density; Dementia; Etidronic Acid; Hip Fractures; Humans; Hyperparathyroidism

2010

Trials

1 trial available for risedronic acid and Deficiency, Vitamin K

ArticleYear
Monitoring of Risedronate by biochemical bone markers in clinical practice.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 2005, Volume: 88, Issue:suppl 5

    Topics: Alkaline Phosphatase; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Bo

2005